Filing Details

Accession Number:
0001104659-21-142471
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 16:05:34
Reporting Period:
2021-11-19
Accepted Time:
2021-11-22 16:05:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1736243 Acurx Pharmaceuticals Inc. ACXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271123 P David Luci C/O Acurx Pharmaceuticals, Inc.,
259 Liberty Avenue
Staten Island NY 10305
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-19 5,200 $4.80 1,008,723 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,083 Indirect By spouse
Common Stock 35,000 Indirect By child